Total Liabilities for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's latest reported total liabilities is $9.01B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$9.01B
YoY change
-3.4%
5Y CAGR
+4.6%
Peak year (2024)
$9.26B
Latest annual
$8.94B
Total Liabilities history chart for Quest Diagnostics (DGX) from 1996 to 2025
Total Liabilities history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $8.94B | -3.4% | ||
| 2024 | $9.26B | +21.7% | ||
| 2023 | $7.60B | +11.3% | ||
| 2022 | $6.83B | -3.1% | ||
| 2021 | $7.05B | -1.2% | ||
| 2020 | $7.13B | +0.8% | ||
| 2019 | $7.08B | +25.1% | ||
| 2018 | $5.66B | +3.5% | ||
| 2017 | $5.47B | +2.0% | ||
| 2016 | $5.36B | +3.6% | ||
| 2015 | $5.18B | -6.6% | ||
| 2014 | $5.55B | +11.5% | ||
| 2013 | $4.97B | -2.4% | ||
| 2012 | $5.10B | -8.9% | ||
| 2011 | $5.60B | +25.1% | ||
| 2010 | $4.47B | -1.7% | ||
| 2009 | $4.55B | -5.1% | ||
| 2008 | $4.80B | -8.4% | ||
| 2007 | $5.24B | +98.4% | ||
| 2006 | $2.64B | +3.9% | ||
| 2005 | $2.54B | +32.8% | ||
| 2004 | $1.92B | +0.4% | ||
| 2003 | $1.91B | +22.6% | ||
| 2002 | $1.56B | -2.5% | ||
| 2001 | $1.59B | -13.0% | ||
| 2000 | $1.83B | -9.1% | ||
| 1999 | $2.02B | +154.4% | ||
| 1998 | $792.30M | -7.8% | ||
| 1997 | $859.20M | +0.3% | ||
| 1996 | $856.35M | — |
Total Liabilities values are taken from Quest Diagnostics's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual total liabilities for Quest Diagnostics (DGX) came in at $8.94B – edged down 3.4% year-over-year.
Across 2020–2025 (5 years), Quest Diagnostics total liabilities produced a CAGR of +4.6% – with the latest reading among the more recent periods of the dataset.
2024 marks the peak total liabilities at $9.26B, with the historical low of $792.30M recorded in 1998.
Quest Diagnostics (DGX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Quest Diagnostics Total Liabilities by Year
Quest Diagnostics Total Liabilities 2025: $8.94B
Quest Diagnostics total liabilities in 2025 was $8.94B, edged down 3.4% below 2024.
Quest Diagnostics Total Liabilities 2024: $9.26B
Quest Diagnostics total liabilities in 2024 was $9.26B, grew 21.7% from 2023. This figure represents the highest annual value in the available history.
Quest Diagnostics Total Liabilities 2023: $7.60B
Quest Diagnostics total liabilities in 2023 was $7.60B, grew 11.3% from 2022.
Quest Diagnostics Total Liabilities 2022: $6.83B
Quest Diagnostics total liabilities in 2022 was $6.83B, edged down 3.1% below 2021.
Quest Diagnostics Total Liabilities 2021: $7.05B
Quest Diagnostics total liabilities in 2021 was $7.05B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Total Liabilities
Companies in the same sector as Quest Diagnostics, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's total liabilities?
- Latest reported total liabilities for Quest Diagnostics (DGX) is $9.01B (period ending March 31, 2026).
How has Quest Diagnostics total liabilities changed year-over-year?
- Quest Diagnostics (DGX) total liabilities changed -3.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics total liabilities?
- Quest Diagnostics (DGX) total liabilities compound annual growth rate is +4.6% over the most recent 5 years available.
When did Quest Diagnostics total liabilities hit its highest annual value?
- Quest Diagnostics total liabilities reached its highest annual value of $9.26B in 2024.
What was Quest Diagnostics total liabilities in 2024?
- Quest Diagnostics (DGX) total liabilities in 2024 was $9.26B.
What was Quest Diagnostics total liabilities in 2025?
- Quest Diagnostics (DGX) total liabilities in 2025 was $8.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.